Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 20/20 | 0.72 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.68 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.68 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.68 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL945858 | 1.00 | S1PR1 (0.72) | S1PR1S1PR2S1PR4S1PR3S1PR5 | |
| SCHEMBL947472 | 0.85 | S1PR1 (0.69) | S1PR1S1PR2S1PR4S1PR3S1PR5 | |
| SCHEMBL946792 | 0.84 | S1PR1 (1.00) | S1PR1S1PR2S1PR4S1PR3S1PR5 | |
| SCHEMBL945550 | 0.83 | S1PR1 (1.00) | S1PR1S1PR2S1PR4S1PR3S1PR5 | |
| SCHEMBL947377 | 0.82 | S1PR1 (1.00) | S1PR1S1PR2S1PR4S1PR3S1PR5 | |
| SCHEMBL946655 | 0.81 | S1PR1 (1.00) | S1PR1S1PR2S1PR4S1PR3S1PR5 | |
| SCHEMBL947705 | 0.80 | S1PR1 (0.78) | S1PR1S1PR2S1PR4S1PR3S1PR5 | |
| SCHEMBL945023 | 0.80 | S1PR1 (0.78) | S1PR1S1PR2S1PR4S1PR3S1PR5 | |
| SCHEMBL946794 | 0.80 | S1PR1 (0.72) | S1PR1S1PR2S1PR4S1PR3S1PR5 | |
| SCHEMBL949239 | 0.80 | S1PR1 (0.72) | S1PR1S1PR2S1PR4S1PR3S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011005295-A1 | MODULATORS OF THE SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2011-01-13 | — | — | WO | disclosed |
| WO-2011005295-A1 | MODULATORS OF THE SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2011-01-13 | — | — | WO | disclosed |